Adverse reactions in syphilis therapy

Journal of the American Venereal Disease Association
|December 1, 1976
PubMed

Insights

Syphilis treatment can cause Jarisch-Herxheimer (J-H) reactions, characterized by rapid treponeme destruction. These reactions are significant in specific conditions like syphilitic paresis and pregnancy, with limited evidence for corticosteroid use.

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Neurology

Background:

  • Syphilis treatment reactions stem from treponemal infection, therapy, or their interaction.
  • Jarisch-Herxheimer (J-H) reactions and therapeutic paradox are discussed in relation to syphilis treatment.
  • Antibiotic side effects are common but not the focus of this review.

Purpose of the Study:

  • To review Jarisch-Herxheimer (J-H) reactions and the therapeutic paradox in syphilis treatment.
  • To identify specific clinical situations where J-H reactions are significant.
  • To evaluate the role and efficacy of corticosteroids in managing syphilis treatment reactions.

Main Methods:

  • Literature review focusing on Jarisch-Herxheimer reactions and therapeutic paradox in syphilis.
  • Analysis of clinical significance of J-H reactions in specific patient populations.
  • Discussion of corticosteroid (prednisone) use in conjunction with penicillin for syphilis treatment.

Main Results:

  • J-H reactions are acute, transient episodes linked to rapid treponeme destruction.
  • J-H reactions are most significant in syphilitic paresis, pregnancy, and cranial nerve involvement.
  • The efficacy of corticosteroids for J-H reactions lacks clinical trial data, suggesting limited, short-term use.
  • Therapeutic paradox appears to be of minor significance with no general prevention methods advocated.

Conclusions:

  • Jarisch-Herxheimer reactions are a key consideration in specific syphilis treatment scenarios.
  • Current evidence does not strongly support widespread corticosteroid use for J-H reactions.
  • Therapeutic paradox is not a major clinical concern in syphilis management.

Related Concept Videos

Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...